低剂量率前列腺近距离放疗后下尿路症状的长期变化评估
本研究回顾性纳入2004年8月至2013年12月在岐阜大学医院接受碘-125低剂量率近距离放疗(LDR-BT)的313例局限性前列腺癌患者,采用IPSS、OABSS和IPSS-QOL在治疗前、治疗后1至60个月及之后每年评估症状。结果显示所有评分在LDR-BT后立即恶化,但随时间改善并在18-36个月恢复至基线;随访5年后,几乎所有患者OABSS较基线显著恶化,尽管5年内有逐渐改善。
要点
- LDR-BT后下尿路症状立即恶化,但多在18-36个月恢复至基线水平。
- 随访5年后OABSS在几乎所有患者中较基线显著恶化。
- 5年内OABSS有逐渐改善,但长期仍可能进展。
核心结论
- LDR-BT后下尿路症状短期恶化但18-36个月恢复至基线,5年后OABSS在几乎所有患者中较基线显著恶化。
研究设计与样本
- 回顾性研究纳入2004年8月至2013年12月在岐阜大学医院接受LDR-BT的313例局限性前列腺癌患者。
主要发现
- 所有评分在LDR-BT后立即较术前恶化。
- 症状随时间改善并在18-36个月恢复至基线。
- 随访5年后OABSS在几乎所有患者中较基线显著恶化,尽管5年内有逐渐改善。
临床怎么用
- 可为局限性前列腺癌患者选择治疗方式及长期生存者的管理提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate long-term changes in lower urinary tract symptoms in patients with prostate cancer (PCa) who underwent low-dose-rate brachytherapy with iodine-125 (LDR-BT). PATIENTS AND METHODS: In this retrospective study, 313 patients with localized PCa underwent LDR-BT at Gifu University hospital between August 2004 and December 2013. The International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score (OABSS), and quality of life due to urinary symptoms (IPSS-QOL) were measured before LDR-BT; at 1, 3, 6, 9, 12, 24, 36, 48, and 60 months after LDR-BT; and annually thereafter. Study endpoints were chronological changes in IPSS, OABSS, and IPSS-QOL compared to pretreatment values. A multivariable nonlinear regression model with robust sandwich estimator evaluated association between outcomes and time with adjustment for covariates. RESULTS: All scores worsened immediately after LDR-BT compared to preoperative scores. However, symptoms improved with time and returned to baseline in 18-36 months. After a 5-year follow-up after LDR-BT, OABSS significantly worsened in almost all patients compared to baseline although there were gradual improvements in less than 5 years after LDR-BT. CONCLUSIONS: Our results may be of clinical importance in selecting treatment modalities for patients with localized PCa and long-term survival after definitive therapy.
引用
- Iinuma K, Nakano M, Kato T, et al. Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy. Urology. 2020. PMID: 32416115. doi:10.1016/j.urology.2020.04.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。